医学
米诺地尔
非那雄胺
脱发
食品药品监督管理局
二氢睾酮
头发周期
睾酮(贴片)
皮肤病科
生理学
内科学
药理学
雄激素
毛发生长
癌症
前列腺
激素
作者
Tymon Tai,Amit Kochhar
标识
DOI:10.1016/j.fsc.2020.01.004
摘要
Androgenetic alopecia (AGA) is the most common hair loss disorder in men and women. The characteristic and reproducible balding pattern in AGA negatively affects self-image and the external perceptions of the balding patient. The phenotypical changes are driven by dihydrotestosterone (DHT) and its precursor testosterone. DHT induces follicle miniaturization and hair cycle changes until resulting hairs no longer extrude through the skin surface. AGA is inherited in a polygenetic pattern and is susceptible to epigenetic and environmental factors. Currently, minoxidil, finasteride, and photolaser therapy are the only Food and Drug Administration–approved medical treatments for AGA.
科研通智能强力驱动
Strongly Powered by AbleSci AI